Cancer News and Research

Latest Cancer News and Research

Proton Partners International to open three Proton Beam Therapy centres in UK

The UK is to get its first three Proton Beam Therapy centres, marking a significant breakthrough in the provision of cancer treatment.

8 Apr 2015

Northwestern University researchers find safer way to improve surgery outcomes

A Northwestern University research team potentially has found a safer way to keep blood vessels healthy during and after surgery.

7 Apr 2015

Quebec Breast Cancer Foundation announces $4.5M investment for 9 homegrown researchers

The Quebec Breast Cancer Foundation is proud to announce a $4.5 million investment for 9 homegrown researchers, thanks to the continued generosity of its donors and partners.

7 Apr 2015

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

Delcath Systems, Inc. announces the expansion of its global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer.

7 Apr 2015

CXCR3 molecule is key mediator of melanoma metastasis, shows research

In a unique partnership demonstrating excellence in "team science," Dartmouth investigators from Norris Cotton Cancer Center identified a role for the molecule CXCR3 (widely known to regulate the migration of immune cells) as a key mediator of melanoma metastasis.

7 Apr 2015

RNA could be a potential target for new anticancer drugs, say UC Berkeley scientists

Most of today's anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of California, Berkeley, scientists unveils a whole new set of potential targets: the RNA intermediaries between DNA and proteins.

7 Apr 2015

CVS Health Foundation announces new grant recipients to increase access to health care

The CVS Health Foundation, a private foundation created by CVS Health Corporation (NYSE: CVS), today announced 55 new grant recipients as part of its multi-year, $5 million commitment to increase access to health care in communities nationwide.

7 Apr 2015

Study: Key signaling pathway in B-cell lymphoma can be blocked using compounds

Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer.

7 Apr 2015

Common cancers deform mitochondria to create conducive environment for tumor growth

In a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine have shown that many cancers - including nearly all pancreatic cancers - enslave and deform mitochondria, the powerhouses of cells, to create an environment more conducive to tumor growth.

7 Apr 2015

Arvinas, Merck team up to create new therapeutics using protein degradation technology

Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.

7 Apr 2015

MGH investigators identify inflammatory molecule that plays key role in lupus

Massachusetts General Hospital (MGH) investigators have identified an inflammatory molecule that appears to play an essential role in the autoimmune disorder systemic lupus erythematosus, commonly known as lupus.

7 Apr 2015

Study estimates prevalence of treatment-related chronic diseases among childhood cancer survivors

The number of childhood cancer survivors in the U.S. has increased, but the majority of those who have survived five or more years after diagnosis face chronic health problems related to their treatment, according to a new Northwestern Medicine study in collaboration with the National Cancer Institute (NCI) and St. Jude Children's Research Hospital.

7 Apr 2015

Around 90% of all breast cancers can be diagnosed using MRI, shows study

Around 90 per cent of all breast cancers can be definitively diagnosed using magnetic resonance imaging (MRI). This compares to the combined methods of mammography and ultrasound which yielded a detection rate of just 37.5 per cent.

7 Apr 2015

New model can help predict how humans adapt to high- and low-altitude hypoxia

There are few times in life when one should aim for suboptimal performance, but new research at Rice University suggests scientists who study metabolism and its role in evolution should look for signs of just that.

7 Apr 2015

Graphic warning labels can motivate smokers to quit

Young adults are more likely to appreciate the dangers of smoking when warnings are presented in images as well as text, according to a new study by a Washington State University Vancouver psychologist.

7 Apr 2015

Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

A new study from the University of Michigan Comprehensive Cancer Center finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer.

7 Apr 2015

MabVax closes $11.6 million in private placement

MabVax Therapeutics Holdings, Inc., a clinical-stage cancer immunotherapy company, is pleased to announce that it has closed on gross proceeds of approximately $11.6 million in a private placement (the "Private Placement") led by OPKO Health, Inc. and Dr. Phillip Frost, CEO and Chairman of OPKO Health.

6 Apr 2015

Regular consumption of nuts reduce mortality by more than 20%

Nuts are a key element of a healthy diet. According to The World Health Organization (WHO), a healthy diet including nuts, regular exercise, the maintenance of ideal weight and staying away from tobacco and alcohol could be sufficient to prevent cancer cases.

6 Apr 2015

Natera raises $55.5 million in funding led by Sofinnova Ventures

Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.

From Natera 6 Apr 2015

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

6 Apr 2015

Cancer News and Research

Latest Cancer News and Research

Proton Partners International to open three Proton Beam Therapy centres in UK

Northwestern University researchers find safer way to improve surgery outcomes

Quebec Breast Cancer Foundation announces $4.5M investment for 9 homegrown researchers

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

CXCR3 molecule is key mediator of melanoma metastasis, shows research

RNA could be a potential target for new anticancer drugs, say UC Berkeley scientists

CVS Health Foundation announces new grant recipients to increase access to health care

Study: Key signaling pathway in B-cell lymphoma can be blocked using compounds

Common cancers deform mitochondria to create conducive environment for tumor growth

Arvinas, Merck team up to create new therapeutics using protein degradation technology

MGH investigators identify inflammatory molecule that plays key role in lupus

Study estimates prevalence of treatment-related chronic diseases among childhood cancer survivors

Around 90% of all breast cancers can be diagnosed using MRI, shows study

New model can help predict how humans adapt to high- and low-altitude hypoxia

Graphic warning labels can motivate smokers to quit

Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

MabVax closes $11.6 million in private placement

Regular consumption of nuts reduce mortality by more than 20%

Natera raises $55.5 million in funding led by Sofinnova Ventures

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in